|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
FIDSON HEALTHCARE PHARMACEUTICALS PLC
Main Activities: Chemical Manufacturing - Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name FIDSON HEALTHCARE PHARMACEUTICALS PLC Headquarters Corporate Head Office 6 IIupeju bye-pass,Ilupeju, Lagos, Nigeria; Lagos; Lagos |
Status: Listed Legal Form: Other non-liability limited Operational Status: Operational ISIN CODE : NGFIDSON0006 Financial Auditors: Ernst & Young (2010) Tel: +23414933319 |
|
Company Description |
| Fidson Healthcare Limited (Fidson) is a healthcare company in Nigeria. For 15 years, Fidson has continued to play a defining role in the industry landscape of Nigeria. The Company authoritative influence and emergence as a frontline player in the healthcare and pharmaceutical sector lends credence to the quality and efficiency of their products and services. Bagging the ISO 9001:2000 Certification, the Company boast of a quality system that attests to the best of global practices. Innovative products | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the Year of 2012, total net operating revenues increased with 47.31%, from NGN 2,437,734 thousands to NGN 3,591,075 thousands. Operating Results increased from NGN -105,248 thousands to NGN 319,678 thousands. The results of the period reached NGN 152,839 thousands at the end of the period against NGN -188,634 thousands last year. Return on equity (Net income/Total equity) went from -3.70% to 2.91%, the Return On Asset (Net income / Total Asset) went from -2.03% to 1.50% and the Net Profit Margin (Net Income/Net Sales) went from -7.74% to 4.26% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 94.51% compared to 82.47% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.11 to 1.06 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Y (cons) |
2012 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
10,221,442 |
0 |
| ||
Current Assets |
4,263,585 |
0 |
| ||
Total Liabilities |
4,966,554 |
0 |
| ||
Shareholders Equity |
5,254,888 |
0 |
| ||
Current Liabilities |
4,004,172 |
0 |
| ||
| * All the accounts are in NGN. | ||
Income Statement
| ||
Total Operating Revenue |
3,591,075 |
7,166,215 |
| ||
Operational Profit (Loss) |
319,678 |
555,198 |
| ||
Net Profit (Loss) |
152,839 |
83,214 |
| ||
| * All the accounts are in NGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
1.5% |
|
| ||
Annualised Return on Assets (ROA) |
1.5% |
|
| ||
Return on Equity (ROE) |
2.91% |
|
| ||
Annualised Return on Equity (ROE) |
2.91% |
|
| ||
Return on Sales (ROS) |
4.29% |
1.17% |
| ||
Return on Capital |
2.75% |
|
| ||
Gross Profit Margin |
56% |
56.72% |
| ||
Operating Profit Margin |
8.23% |
6.93% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
1.66x |
|
| ||
Inventory Turnover |
2.49x |
|
| ||
Current asset turnover |
0.84x |
|
| ||
Fixed-asset turnover |
0.60x |
|
| ||
Asset Turnover |
0.35x |
|
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
319,678 |
555,198 |
| ||
EBITDA |
319,678 |
555,198 |
| ||
Enterprise value |
9,375,934 |
7,199,999 |
| ||
Enterprise Value / EBITDA |
29.33 |
12.97 |
| ||
Bookvalue (BV) |
8,258,889 |
0 |
| ||
Net Cash |
-3,992,554 |
0 |
| Liquidity Ratios | ||
| ||
Current Ratio |
106.48% |
|
| ||
Quick ratio |
90.73% |
|
| ||
Doom's day ratio |
0.29% |
|
| Leverage Ratios | ||
| ||
Leverage ratio |
194.51% |
|
| ||
Interest Coverage Ratio |
315.46% |
174.12% |
| ||
Debt to equity |
94.51% |
|
| ||
Debt to total assets |
48.59% |
|
| ||
Long Term Debt to Capital |
100% |
|
| ||
Debt / Enterprise Value |
20.93% |
0% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
23.23 |
12.97 |
| ||
Price/Book Ratio |
0.16 |
|
| ||
Market Cap / Net cash |
-1.86 |
|
| Trend Ratios | ||
| ||
Revenue Trend |
147.55% |
294.01% |
| ||
Net Income Trend |
-81.02% |
-44.11% |
| ||
Operating Income Trend |
-303.74% |
-527.51% |
| ||
 |